Aspen announces the launch of Tramaspen SR

Aspen Pharmacare, a renowned pharmaceutical company, has recently unveiled a groundbreaking addition to its product line – TRAMASPEN SR. This new range of sustained-release tramadol hydrochloride tablets comes in three strengths: 100 mg, 150 mg, and 200 mg.

The launch of TRAMASPEN SR marks a significant milestone in pain management, offering healthcare professionals and patients a versatile and effective solution for moderate to severe pain.

Product Description and Indications

TRAMASPEN SR is designed to provide long-lasting pain relief for adults and children aged 12 years and older. Each tablet contains a specific dosage of tramadol hydrochloride – 100 mg, 150 mg, or 200 mg, tailored to meet varying pain management needs.

The sustained-release formulation ensures a steady release of the active ingredient, allowing for extended pain control and improved patient compliance.

Key Features and Benefits:

• Comprehensive Range: TRAMASPEN SR offers a complete range of strengths, providing healthcare professionals with flexibility in prescribing based on individual patient requirements.
• Efficacy: Tramadol hydrochloride is a well-established analgesic known for its effectiveness in managing moderate to severe pain, making TRAMASPEN SR a reliable choice for pain relief.
• Accessibility: TRAMASPEN SR is readily available from regular wholesalers, ensuring convenient access for healthcare providers and patients.

Pricing and Packaging

The pricing of TRAMASPEN SR is competitive, with pack sizes of 60 tablets for each strength. The product is listed with NAPPI codes for easy identification and ordering. The transparent pricing structure aims to make TRAMASPEN SR an affordable option for healthcare facilities and patients alike.

Contact Information:

For further information about TRAMASPEN SR, healthcare professionals can reach out to Gregory Sebalo, Brand Manager at Aspen Pharmacare, directly via phone or email. Additionally, a Customer Careline is available for any inquiries or assistance related to the product.

Conclusion:

In conclusion, the launch of TRAMASPEN SR by Aspen Pharmacare represents a significant advancement in pain management therapy. With its diverse range of strengths, sustained-release formulation, and proven efficacy, TRAMASPEN SR is poised to make a positive impact on the lives of individuals suffering from moderate to severe pain. Healthcare professionals can confidently consider TRAMASPEN SR as a valuable addition to their armamentarium for pain relief.

Aspen Pharmacare’s commitment to innovation and quality shines through in the introduction of TRAMASPEN SR, setting a new standard in the field of pain management. For healthcare professionals seeking a reliable and effective solution for pain control, TRAMASPEN SR stands out as a promising choice.